Dr. Ivy serves as the Vice Chief Medical Officer for the Sickle Cell Disease Association of America (SCDAA). Prior to joining SCDAA, Dr. Ivy worked with the Maternal and Child Health Bureau (MCHB) of the Health Resources and Services Administration (HRSA) as the Program Director of the Hemoglobinopathies Program, which included the Sickle Cell Disease Treatment Demonstration Program (SCDTDP), the Sickle Cell Disease Newborn Screening Program (SCDNBSP) and the Thalassemia Program.
Dr. Ivy worked at the National Heart, Lung and Blood Institute (NHLBI) of the National Institutes of Heath where he was part of the team that developed the NHLBI Sickle Cell Disease Treatment Recommendations of 2014. Dr. Ivy completed his medical school training at East Carolina University School of Medicine. After starting a residency in Pediatrics, Dr. Ivy attended the University of North Carolina at Chapel Hill School of Public Health
